OBIO icon

Orchestra BioMed

53 hedge funds and large institutions have $129M invested in Orchestra BioMed in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
11
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
DKCM
1
Davidson Kempner Capital Management
New York
$9.75M 975,213
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$8.06M 800,000
BlackRock
3
BlackRock
New York
$8.04M 797,348
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$7.99M 798,683 -9,082 -1%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$7.79M 778,782 +526,264 +208%
PI
6
Putnam Investments
Massachusetts
$7.5M 750,000
RCM
7
RA Capital Management
Massachusetts
$6.3M 625,000
AC
8
Amitell Capital
Singapore
$6.05M 600,139 +44,869 +8%
O
9
OrbiMed
New York
$5.04M 500,000
PA
10
Perceptive Advisors
New York
$4.54M 450,000
KPF
11
K2 Principal Fund
Ontario, Canada
$4.29M 425,541 +5,192 +1%
WP
12
Woodline Partners
California
$4.07M 403,699
APM
13
Avidity Partners Management
Texas
$4.03M 400,000
BC
14
Boxer Capital
California
$4.03M 400,000
EC
15
EcoR1 Capital
California
$4.03M 400,000
ACP
16
Acuta Capital Partners
California
$3.96M 392,500
M
17
Murchinson
Ontario, Canada
$3.02M 300,000
AAA
18
Affinity Asset Advisors
New York
$3M 300,000
WAM
19
Weiss Asset Management
Massachusetts
$2.96M 296,304 +180,482 +156%
Citadel Advisors
20
Citadel Advisors
Florida
$2.63M 263,281 +3,457 +1%
SCM
21
Sio Capital Management
New York
$2.52M 250,000
GL
22
Governors Lane
New York
$2.52M 250,000
KKRC
23
Kohlberg Kravis Roberts & Co
New York
$1.7M 168,985 +168,985 New
BFM
24
Boothbay Fund Management
New York
$1.67M 165,891 -17,115 -9%
ASM
25
ATW SPAC Management
New York
$1.58M 157,159